116 related articles for article (PubMed ID: 19467309)
1. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.
Allard E; Huynh NT; Vessières A; Pigeon P; Jaouen G; Benoit JP; Passirani C
Int J Pharm; 2009 Sep; 379(2):317-23. PubMed ID: 19467309
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.
Allard E; Jarnet D; Vessières A; Vinchon-Petit S; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2010 Jan; 27(1):56-64. PubMed ID: 19908129
[TBL] [Abstract][Full Text] [Related]
4. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
[TBL] [Abstract][Full Text] [Related]
5. Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.
Clavreul A; Montagu A; Lainé AL; Tétaud C; Lautram N; Franconi F; Passirani C; Vessières A; Montero-Menei CN; Menei P
Int J Nanomedicine; 2015; 10():1259-71. PubMed ID: 25709447
[TBL] [Abstract][Full Text] [Related]
6. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
[TBL] [Abstract][Full Text] [Related]
7. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
[TBL] [Abstract][Full Text] [Related]
8. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.
Laine AL; Huynh NT; Clavreul A; Balzeau J; Béjaud J; Vessieres A; Benoit JP; Eyer J; Passirani C
Eur J Pharm Biopharm; 2012 Aug; 81(3):690-3. PubMed ID: 22561953
[TBL] [Abstract][Full Text] [Related]
9. The adaptation of lipid nanocapsule formulations for blood administration in animals.
Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules.
Lainé AL; Clavreul A; Rousseau A; Tétaud C; Vessieres A; Garcion E; Jaouen G; Aubert L; Guilbert M; Benoit JP; Toillon RA; Passirani C
Nanomedicine; 2014 Nov; 10(8):1667-77. PubMed ID: 24842766
[TBL] [Abstract][Full Text] [Related]
12. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse.
Resnier P; Galopin N; Sibiril Y; Clavreul A; Cayon J; Briganti A; Legras P; Vessières A; Montier T; Jaouen G; Benoit JP; Passirani C
Pharmacol Res; 2017 Dec; 126():54-65. PubMed ID: 28159700
[TBL] [Abstract][Full Text] [Related]
13. Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model.
David S; Montier T; Carmoy N; Resnier P; Clavreul A; Mével M; Pitard B; Benoit JP; Passirani C
J Gene Med; 2012 Dec; 14(12):769-75. PubMed ID: 23143656
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
Zanotto-Filho A; Coradini K; Braganhol E; Schröder R; de Oliveira CM; Simões-Pires A; Battastini AM; Pohlmann AR; Guterres SS; Forcelini CM; Beck RC; Moreira JC
Eur J Pharm Biopharm; 2013 Feb; 83(2):156-67. PubMed ID: 23219677
[TBL] [Abstract][Full Text] [Related]
15. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
[TBL] [Abstract][Full Text] [Related]
16. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
17. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C
Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure.
Idlas P; Lepeltier E; Bastiat G; Pigeon P; McGlinchey MJ; Lautram N; Vessières A; Jaouen G; Passirani C
Langmuir; 2023 Feb; 39(5):1885-1896. PubMed ID: 36693216
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
20. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
